ES358505A1 - Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas. - Google Patents

Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.

Info

Publication number
ES358505A1
ES358505A1 ES358505A ES358505A ES358505A1 ES 358505 A1 ES358505 A1 ES 358505A1 ES 358505 A ES358505 A ES 358505A ES 358505 A ES358505 A ES 358505A ES 358505 A1 ES358505 A1 ES 358505A1
Authority
ES
Spain
Prior art keywords
nylon
mixtures
sustained release
release tablet
tablet coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES358505A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SIXTEN ENGLESSON TEKNISK KONSULT
Original Assignee
SIXTEN ENGLESSON TEKNISK KONSULT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SIXTEN ENGLESSON TEKNISK KONSULT filed Critical SIXTEN ENGLESSON TEKNISK KONSULT
Publication of ES358505A1 publication Critical patent/ES358505A1/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES358505A 1967-09-04 1968-09-25 Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas. Expired ES358505A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE1219667A SE324859B (de) 1967-09-04 1967-09-04

Publications (1)

Publication Number Publication Date
ES358505A1 true ES358505A1 (es) 1970-04-16

Family

ID=20295314

Family Applications (1)

Application Number Title Priority Date Filing Date
ES358505A Expired ES358505A1 (es) 1967-09-04 1968-09-25 Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.

Country Status (7)

Country Link
AT (1) AT280478B (de)
BE (1) BE720383A (de)
ES (1) ES358505A1 (de)
FR (1) FR8105M (de)
GB (1) GB1186990A (de)
NL (1) NL6812365A (de)
SE (1) SE324859B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU174057B (hu) * 1976-09-17 1979-10-28 Richter Gedeon Vegyeszet Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
ATE47519T1 (de) * 1982-07-08 1989-11-15 Leo Ab Tabletten mit verzoegerter freisetzung sowie verfahren zu deren herstellung.
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
CA1239034A (en) * 1984-08-17 1988-07-12 Kelly L. Smith Delivery system
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
CN100453531C (zh) * 1998-10-09 2009-01-21 味之素株式会社 半胱氨酸衍生物

Also Published As

Publication number Publication date
BE720383A (de) 1969-02-17
NL6812365A (de) 1969-03-06
AT280478B (de) 1970-04-10
SE324859B (de) 1970-06-15
GB1186990A (en) 1970-04-08
FR8105M (de) 1970-07-27

Similar Documents

Publication Publication Date Title
Meltzer et al. Effect of intramuscular injections on serum creatine phosphokinase activity
ZA912793B (en) Pharmaceutical formulations
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
FI86373B (fi) Belaeggning foer en farmaceutiskt tablett med foerdroejd effekt och foerfarande foer framstaellning av en tablett.
GB1378348A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
ES358505A1 (es) Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.
NL155264B (nl) Werkwijze voor de bereiding van een in water onoplosbaar chelaat van een biologisch werkzaam aminozuur, zuuramide of aminoglycoside, alsmede een geheel of gedeeltelijk uit zo'n onoplosbaar chelaat bestaand gevormd voortbrengsel.
BE755924A (fr) Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
GB1210968A (en) Improvements in or relating to the treatment of gastric ailments
Clark et al. Emergence of resistant organisms as a function of dose in oxolinic acid therapy
Elsmore Saccharine aversion induced by delta-9-tetrahydrocannabinol: Effects of repeated doses prior to pairing with saccharine.
Rubin Serum salicylate levels in osteoarthritis following oral administration of a preparation containing salicylsalicylic acid and acetylsalicylic acid
ES361702A1 (es) Un procedimiento para la preparacion de sales de acido oro-tico yno acido dihidroorotico.
ES265597A1 (es) Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicina
IE38235L (en) Combatting swine dysentery
GB1019111A (en) Salts of 5-amino-isoindoline
ISHIHARA et al. Experimental investigation on the pathogenesis of tartrazine-induced asthma
GB908634A (en) Pharmaceutical compositions containing pararosaniline or derivatives thereof
GB1110397A (en) Ephedrine composition
JPS51123834A (en) A medicine against the headache
GB1284884A (en) A new insoluble salt of kanamycin
GB1350309A (en) Acetylsalicylic acid derivative method for its preparation and therapeutic composition containing same
TH17624A (th) สูตรผสมทางสัตวแพทย์
Nagai et al. Clinical studies on enoxacin in urinary tract infection
Kondrashkova et al. Changed RNA content of cortical neurons caused by Frenolon.